Cleveland Clinic Abu Dhabi unveils innovative technologies to advance cancer care

UAE—Cleveland Clinic Abu Dhabi has made significant strides in advancing cancer care, unveiling a suite of new technologies and patient-focused initiatives during Abu Dhabi Global Healthcare Week 2025.

These efforts reflect the hospital’s commitment to delivering cutting-edge cancer treatments and enhancing the overall patient experience.

 There is a strong emphasis on supportive care during the most challenging phases of treatment.

Dr. Stephen R. Grobmyer, Chair of the Oncology Institute at Cleveland Clinic Abu Dhabi’s Fatima bint Mubarak Centre, explained that the hospital’s approach goes beyond traditional medical interventions.

The primary goal is to provide a holistic, human-centered experience that addresses the physical, emotional, and psychological needs of cancer patients throughout their health journey.

This philosophy is evident in the latest innovations introduced at the center.

One of the most notable advancements is the launch of a remote monitoring program utilizing the BioButton wearable device.

This technology is now being used with cancer patients at the Fatima bint Mubarak Centre.

After discharge, patients wear the BioButton, which continuously tracks vital signs and symptoms.

This real-time data allows healthcare teams to detect early signs of complications and intervene promptly, thereby improving patient safety, comfort, and outcomes during recovery at home.

In addition to remote monitoring, Cleveland Clinic Abu Dhabi has implemented new solutions to tackle some of the most distressing side effects of cancer treatment.

For example, chemotherapy-induced hair loss, which can have a profound psychological impact, is being addressed through the use of a scientifically validated cooling cap.

Patients wear this cap during chemotherapy sessions, and it works by cooling the scalp, significantly reducing hair loss.

This innovation helps patients maintain a sense of normalcy and dignity during their treatment.

Furthermore, the hospital has introduced a hand-cooling system to help prevent nerve damage and chemotherapy-induced neuropathy, a common and often debilitating side effect of certain cancer treatments.

By cooling the hands during therapy, this system reduces the risk of nerve injury, helping patients retain hand function and quality of life.

These technological and therapeutic advancements are part of a broader strategy at Cleveland Clinic Abu Dhabi to centralize and streamline cancer care.

The new nine-story oncology center, modeled after leading international cancer centers, brings together advanced imaging, infusion, radiation, and chemotherapy services under one roof.

This integrated approach ensures that patients receive coordinated, multidisciplinary care tailored to their individual needs.

Moreover, the Oncology Institute is expanding access to genetic testing and clinical trials, aiming to personalize cancer treatment and contribute to global cancer research.

 The hospital’s efforts also extend to cancer prevention and early detection, with comprehensive screening programs for various types of cancer.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.